Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on September 5th, 2012% Veena Misra (North Carolina State Univ.)
North Carolina State University in Raleigh will lead a group of universities in the U.S., Australia, and Asia to develop self-powered health monitoring sensors and devices. Some 30 industry partners are expected to join the five-year, $18.5 million consortium, known as the Center for Advanced Self-Powered Systems . . . → Read More: University Consortium to Research Nanotech Health Monitors
By Alan, on June 7th, 2012% Collapse of the 15-story Alto Rió condominium tower in Concepción, Chile, following the magnitude 8.8 earthquake in 2010 (John Wallace, UCLA)
Engineers at University of California in Los Angeles (UCLA) and UC-Berkeley will study the impact of building construction practices, particularly the design and performance of structural walls, on resisting earthquake damage. The . . . → Read More: Grant to Fund Research on Earthquakes, Building Design
By Alan, on May 22nd, 2012% Hiro and a human colleague (Tecnalia)
Engineers at the Tecnalia Research and Innovation Centre in San Sebastián, Spain will further develop the intelligence of a Japanese humanoid robot to enable the device to work along side humans in European factories. The robot model, known as Hiro — short for Human Interactive Robot — . . . → Read More: Japanese Robot to be Adapted for Work with Humans
By Alan, on May 14th, 2012% E coli bacteria magnified (USDA Agricultural Research Service/Wikimedia Commons)
Researchers from North Carolina and Japan have devised a light-emitting diode (LED) process that uses ultraviolet (UV) light to kill pathogens such as bacteria and viruses. Their discoveries are described in the May issue of the journal Applied Physics Letters (paid subscription required).
The . . . → Read More: LED Process Adapts Ultraviolet Light to Kill Pathogens
By Alan, on April 17th, 2012% Igaki-Tamai stent (Kyoto Medical Planning Co.)
Researchers in Japan and the Netherlands completed a 10-year study that found a stent that degrades and is absorbed into the blood vessel tissue to be safe for patients with coronary artery disease. The findings are published online ahead of print in the journal Circulation.
Stents are . . . → Read More: Degradable Stent Found Safe for Long Term Coronary Treatment
By Alan, on March 8th, 2012% Guayule (Agricultural Research Service/USDA)
Bridgestone Corporation, a global tire manufacturer in Tokyo, Japan unveiled plans today for a research project in the U.S. to develop a new commercially viable, renewable source of tire-quality natural rubber. The project aims to harness the cultivation of guayule — pronounced why-YOU-lee — as an alternative to hevea . . . → Read More: Bridgestone Tire to Study Natural Raw Rubber Alternative
By Alan, on March 7th, 2012% Rotavirus (CDC.gov)
Medicago Inc. in Quebec City, Canada and Mitsubishi Tanabe Pharma Corp. in Osaka, Japan have agreed to develop and commercialize at least three new vaccines based on Medicago’s technology. The first part of the deal is expected to provide Medicago with up to $C33 million ($US 33 milion) in revenues.
The . . . → Read More: Biotech, Pharma Companies to Collaborate on New Vaccines
By Alan, on February 6th, 2012% (Intel Corp.)
The Semiconductor Industry Association (SIA) in Washington, D.C. says worldwide semiconductor sales for 2011 reached a record $299.5 billion, an annual increase of 0.4 percent from $298.3 billion recorded in 2010. But sales for semiconductors at the end of 2011 dropped off compared to the same period in the previous year.
. . . → Read More: Semiconductor Sales Gain in 2011, Decline in 4th Quarter
By Alan, on February 1st, 2012% (Photos8.com)
A phase 3 clinical trial has shown a new drug to treat prostate cancer is effective with patients who had previously been treated with chemotherapy. The results of the study of MDV3100 — made by the biopharmaceutical company Medivation Inc. in San Francisco and Astellas Pharma Inc. in Tokyo, Japan — will . . . → Read More: Prostate Cancer Therapy Shown Effective in Chemo Patients
By Alan, on January 26th, 2012% Influenza ultrastructure illustration (Dan Higgins, CDC)
Researchers at the RIKEN Omics Science Center in Yokohama, Japan have developed a new technique to identify influenza virus infection in only 40 minutes and with 100 times the sensitivity of conventional methods. The findings from the team led by RIKEN Omics’ Toshihisa Ishikawa appear in the . . . → Read More: Faster, More Sensitive Flu Diagnostics Developed
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|
You must be logged in to post a comment.